BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3336915)

  • 1. Nephrotoxicity of cyclosporine A and cyclosporine G in a rat model.
    Tejani A; Lancman I; Pomrantz A; Khawar M; Chen C
    Transplantation; 1988 Jan; 45(1):184-7. PubMed ID: 3336915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of less chronic nephrotoxicity by cyclosporine G than cyclosporine A in a low-salt rat model.
    Burdmann EA; Rosen S; Lindsley J; Elzinga L; Andoh T; Bennett WM
    Transplantation; 1993 May; 55(5):963-6. PubMed ID: 8497907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular hemodynamics in cyclosporine nephrotoxicity following uninephrectomy.
    Winston JA; Feingold R; Safirstein R
    Kidney Int; 1989 May; 35(5):1175-82. PubMed ID: 2770102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative toxicological study of cyclosporine and Nva2-cyclosporine in Sprague-Dawley rats.
    Duncan JI; Thomson AW; Simpson JG; Davidson RJ; Whiting PH
    Transplantation; 1986 Oct; 42(4):395-9. PubMed ID: 3765053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of experimental nephrotoxicity with fish oil as the vehicle for cyclosporine.
    Elzinga L; Kelley VE; Houghton DC; Bennett WM
    Transplantation; 1987 Feb; 43(2):271-4. PubMed ID: 3810835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deleterious effect of cyclosporins on the ischemic kidney in the rat and the protection by the calcium antagonist verapamil.
    Ar'Rajab A; Dawidson IJ; Harris RB; Mileski WJ; Sentementes JT
    J Am Soc Nephrol; 1994 Jul; 5(1):93-101. PubMed ID: 7948788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A.
    Burdmann EA; Andoh TF; Rosen S; Lindsley J; Munar MY; Elzinga LW; Bennett WM
    Kidney Int; 1994 Mar; 45(3):684-91. PubMed ID: 8196271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of cyclosporine A and Nva2-cyclosporine (cyclosporine G) in a rat renal allograft model.
    Grant D; Zhong R; Stiller C; Wallace C; Keown P; Duff J
    Transplantation; 1987 Jul; 44(1):9-12. PubMed ID: 3299927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress-mediated renal dysfunction by cyclosporine A in rats: attenuation by trimetazidine.
    Satyanarayana PS; Chopra K
    Ren Fail; 2002 May; 24(3):259-74. PubMed ID: 12166693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine nephrotoxicity in the Fischer rat.
    Verani R
    Clin Nephrol; 1986; 25 Suppl 1():S9-13. PubMed ID: 3708942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of acute nephrotoxicity with low doses of cyclosporin: experimental study in the rat.
    Sabbatini M; De Nicola L; Uccello F; Russo D; Conte G; Dal Canton A; Andreucci VE
    Nephrol Dial Transplant; 1990; 5(1):69-74. PubMed ID: 2109287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of renal denervation and prazosin on GFR and renal blood flow after cyclosporine in rats.
    Murray BM; Paller MS
    Clin Nephrol; 1986; 25 Suppl 1():S37-9. PubMed ID: 3708934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for leukotrienes in cyclosporine nephrotoxicity.
    Butterly DW; Spurney RF; Ruiz P; Griffiths R; Albrightson C; Coffman TM
    Kidney Int; 2000 Jun; 57(6):2586-93. PubMed ID: 10844628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic cyclosporine nephrotoxicity. A rodent model.
    Gillum DM; Truong L; Tasby J; Migliore P; Suki WN
    Transplantation; 1988 Aug; 46(2):285-92. PubMed ID: 3406978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the prostaglandin E1 analog misoprostol on cyclosporine nephrotoxicity.
    Paller MS
    Transplantation; 1988 Jun; 45(6):1126-31. PubMed ID: 3132763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary renovascular effects of erythromycin in the rat: relationship to cyclosporine nephrotoxicity.
    McCormack AJ; Snipes RG; Dillon JJ; Yang JJ; Finn WF
    Ren Fail; 1990; 12(4):241-8. PubMed ID: 2100828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of myogenic autoregulation in cyclosporine nephrotoxicity in the rat.
    Kaskel FJ; Deverajan P; Birzgalis A; Moore LC
    Ren Physiol Biochem; 1989; 12(4):250-9. PubMed ID: 2616886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibition and chronic cyclosporine-induced renal dysfunction in type 1 diabetes.
    Hannedouche TP; Natov S; Boitard C; Lacour B; Grünfeld JP
    Nephrol Dial Transplant; 1996 Apr; 11(4):673-8. PubMed ID: 8671857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal dysfunction in animal models of cyclosporine toxicity.
    Paller MS; Murray BM
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):155-9. PubMed ID: 3895656
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose cyclosporin nephrotoxicity in the rat.
    Ferguson CJ; von Ruhland C; Parry-Jones DJ; Griffiths DF; Salaman JR; Williams JD
    Nephrol Dial Transplant; 1993; 8(11):1259-63. PubMed ID: 8302466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.